Intensity Modulated Radiotherapy Market - Emerging Trends & Global Future Forecasts
Major Growth Driving Factors:
Intensity-modulated radiotherapy has grown due to a number of factors, including an increase in the demand for intensity-modulated interventions and the expansion of non-invasive cancer management treatments. As healthcare technologies advance, more growth in this area of treatment is anticipated in the near future. But increased availability and cost are limiting the market's growth.
Driver: An increase in radiation therapy-based non-invasive cancer treatments
More accurate and focused treatments are now possible thanks to developments in radiation therapy technology. Highly targeted radiation can be delivered while sparing healthy tissues and reducing side effects, thanks to techniques like proton therapy, intensity-modulated radiation therapy (IMRT), and stereotactic body radiation therapy (SBRT). Non-invasive radiation therapy does not require tissue removal or surgical incisions, in contrast to surgery. As a result, there is less scarring and patients recover more quickly, returning to their regular activities sooner.
Opportunity: Growing costs for healthcare in developing nations
A complex web of interrelated factors, including evolving demographics, disease trends, better infrastructure, technological advancements, and an expanding healthcare workforce, is responsible for the rise in healthcare spending in developing nations. The way that financial resources are allocated for services and treatments is shaped by this dynamic interaction. In this setting, intensity-modulated radiotherapy (IMRT) stands out as a tactical option because of its cutting-edge features, which complement changing medical requirements.
Download PDF Brochure to Read More@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201922049
Restraint: The dearth of skilled radiologist/oncologist
The scarcity of proficient radiologists and oncologists constitutes a multifaceted challenge underscored by factors including escalating demand, shifting demographics, hurdles in training, work environment considerations, and the imperative for continuous professional advancement. This intricate interplay distinctly contributes to the advancement and market elevation of Intensity-modulated radiotherapy (IMRT), positioning it as an indispensable solution within the realm of oncological care and management.
Challenge: The accessibility of substitute technologies
The IGRT market faces a challenge in navigating the alternative technology landscape, which is fueled by ongoing technological advancements, the desire for better treatment outcomes, and the competitive dynamics inherent in cancer treatment modalities. In this complex environment, intensity-modulated radiotherapy's (IMRT) strategic ascent and market penetration are crucial since it has to successfully match its special qualities to the changing needs of cancer treatment while competing with other technological alternatives.
End User Scenario:
The market for intensity-modulated radiation therapy is expected to be dominated by hospitals between 2022 and 2028.
Hospitals and independent radiotherapy centers are the main end users in the intensity-modulated radiation market. In 2022, hospitals are anticipated to hold a significant portion of the market. The need for effective patient caseload management harmonizes with the accuracy of IMRT tumor-targeting expertise and its simplified treatment delivery. This mutually beneficial convergence enhances patient-centered care and increases the marketability of intensity-modulated radiation therapy, positioning it as a critical therapeutic option for healthcare facilities tackling the intricacies of cancer treatment.
In general, the hospital's end-user segment strategically leverages its state-of-the-art infrastructure, patient-centered care philosophy, synergistic collaborative milieu, and comprehensive healthcare offerings to drive adoption of intensity-modulated radiation therapy (IMRT). The combined effect of these facts clearly promotes the growth and increased visibility of IMRT's presence in the hospital ecosystem, which in turn enhances its market position and traction.
Request Sample Pages for more Detailed Information@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=201922049
Projected Revenue Growth, Globally:
Revenue from intensity-modulated radiation therapy was projected to reach $2.2 billion globally in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.2% to $2.8 billion by 2028.
Geographical Growth Scenario:
By 2022, North America will hold a sizable portion of the market for intensity-modulated radiation.
Over the course of the forecast period, the North American region is anticipated to experience notable growth in the market in 2022. United States and Canada make up North America. The sophisticated healthcare system in North America is linked to a higher cancer incidence. A highly developed healthcare infrastructure and easy access to cutting-edge medical technologies in North America foster an environment that is favorable to the adoption of progressive treatment modalities like intensity-modulated radiotherapy (IMRT).
Key Stakeholders:
# Radiotherapy product manufacturers
# Distributors, suppliers, and commercial service providers
# Healthcare service providers
# Clinical research organizations (CROs)
# Radiotherapy service providers
# Radiotherapy product distributors
# Medical research laboratories
# Cancer care centers
# Cancer research organizations
# Academic medical centers and universities
# Market research and consulting firms
Read the Detailed Report, Here@
https://www.marketsandmarkets.com/Market-Reports/intensity-modulated-radiotherapy-market-201922049.html